“…Results shown in this study, based on PTA, indicate that CI implanted in an ear with P-SNHL is an effective, safe measure to provide stable audibility from the first month of activation. This piece of information is extremely important for the group of patients with AHL because an objective of bimodal adaptations is to obtain better sound perception and ensure hearing through one of the ears, in case the contralateral ear may suffer some type of degenerative pathology, as could potentially be the case with bilateral Meniere's disease [15] , autoimmune hearing loss [16] , otoesclerosis [17] , or some labyrinth malformations [18] . The stable PTA results had already been described by other authors [19,20] , and their homogeneity, regardless of the initial HLs, can be explained by several reasons: 1.)…”